Pharmacological profile of the 5-HT2C receptor agonist WAY-163909; therapeutic potential in multiple indications

CNS Drug Reviews

Volumn 12, Issue 3-4, 2006, Pages 167-177

  Dunlop, John ^a   Marquis, Karen L ^a   Lim, H K ^a   Leung, Louis ^a   Kao, John ^a   Cheesman, Cynthia ^a   Rosenzweig Lipson, Sharon ^a  

^a PFIZER INC   (United States)

Author keywords

5 HT2C receptors; Depression; Obesity; Schizophrenia; Serotonin; WAY 163909

Indexed keywords

1,2,3,4,8,9,10,10A OCTAHYDRO 7BH CYCLOPENTA [B][1,4]DIAZEPINO[6,7,1HI]INDOLE; 1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; APOMORPHINE; CLOZAPINE; HALOPERIDOL; SEROTONIN 3 AGONIST; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; WAY 163909;

ANXIETY DISORDER; DEPRESSION; DOSE RESPONSE; DRUG ACTIVITY; DRUG CLEARANCE; DRUG DOSE ESCALATION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; ELECTROPHYSIOLOGY; ERECTILE DYSFUNCTION; FIRST PASS EFFECT; FOOD INTAKE; HUMAN; HUMAN CELL; LIVER MICROSOME; MICRODIALYSIS; MIGRAINE; MUTAGEN TESTING; NONHUMAN; OBESITY; OBSESSIVE COMPULSIVE DISORDER; OLFACTORY BULBECTOMY; REVIEW; SCHIZOPHRENIA;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; AZEPINES; EATING; HUMANS; INDOLES; RECEPTOR, SEROTONIN, 5-HT2C;

EID: 33845995465     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2006.00167.x     Document Type: Review

References (35)

1. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999;38:1083-1152.
2. Berendsen HH. Interactions between 5-hydroxytryptamine receptor subtypes. Pharmacol Ther 1995;66:17-37.
3. th IUPHAR Satellite Meeting on Serotonin 2002.
4. 2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1- methylethylamines. Improved therapeutics for obsessive compulsive disorder. J Med Chem 1997;40:2762-2769.
5. Cowen PJ, Sargent PA, Williams C, Goodall EM, Orlikov AB. Hypophagic, endocrine and subjective responses to m-chlorophenylpiperzine in healthy men and women. Human Psychopharmacol 1995;10:385-391.
6. Cryan JF, McGrath C, Leonard BE, Norman TR. Combining pindolol and paroxetine in an animal model of chronic antidepressant action - can early onset of action be detected? Eur J Pharmacol 1998;352:23-28.
7. Detke MJ, Rickels M, Lucki, I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995;119:47-54.
8. 2C receptor-selective agonist with anorectic activity. J Pharmacol Exp Ther 2005;313:862-869.
9. 1C receptor activation: A key step in the initiation of migraine? Trends Pharmacol Sci 1989;10:307-309.
10. 2C receptors but not by sympathomimetic effects. Neuropharmacology 1994;33:457-465.
11. Harkin A, Kelly JP, McNamara M, et al. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Eur J Pharmacol 1999;364:123-13.
12. 2C receptor agonist in Zucker rats. Brain Res 2004;1011:221-7.
13. 1B receptor antagonists. Pharmacol Biochem Behav 2004;77:69-75.
14. Kelly JP, Wrynn AS, Leonard BE. The olfactory bulbectomized rat as a model of depression: An update. Pharmacol Ther 1997;74:299-316.
15. 1B receptors. Psychopharmacology 1998;96:93-100.
16. 1C antagonists indicate that receptors mediated mCPP-induced hypophagia. Br J Pharmacol 1991;103:2016-2020.
17. 2C receptor agonist. Eur J Pharmacol 2004;283:37-43.
18. Leshner AI, Remler H, Biegon A, Samuel D. Desmethylimipramine (DMI) counteracts learned helplessness in rats. Psychopharmacology 1979;66:207-208.
19. 2C receptor selective agonist with preclinical antipsychotic-like activity. J Pharmacol Exp Ther 2006 (submitted).
20. 2C receptor agonist, reduces feeding in rodents and produces weight loss in humans. Soc Neurosci Abstr 2001;27:309.2.
21. 2C receptors mediate penile erections in rats: Actions of novel and selective agonists and antagonists. Eur J Pharmacol 1997;325:9-12.
22. Mitchell PJ, Redfern PH. Animal models of depressive illness: The importance of chronic drug treatment. Curr Pharm Design 2005;11:171-203.
23. Redmond AM, McNamara MG, Dredge K, Kelly JP, Leondard BE. Onset of action of venlafaxine, citalopram, and desipramine in the OB rat model of depression. J Psychopharmacol 1997;11:A40.
24. 2C selective agonist WAY-161503. Brain Res 2006;1073-4:240-251.
25. 2C receptor agonist (7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi] inhdole (WAY-163909) in rodents. Psychopharmacology 2006 (Submitted).
26. 2C receptor. Bioorg Med Chem Lett 2004;14:2603-2607.
27. Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S. m-Chlorophenylpiperazine: A central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg's Arch Pharmacol 1979;308:159-163.
28. 1C receptor activation by hallucinogenic drugs. Psychopharmacology 1991;105:340-346.
29. 2C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology 1997;133:209-312.
30. 2C receptors. Nature 1995;374:542-546.
31. 2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology 2003;167:274-80.
32. Vickers SP, Benwell KR, Porter RH, Bickerdike MJ, Kennett GA, Dourish CT. Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. Br J Pharmacol 2000;130:1305-1314.
33. Walsh AE, Smith KA, Oldman AD, Williams C, Goodall EM, Cowen PJ. m-Chlorophenylpiperazine decreases food intake in a test meal. Psychopharmacology 1994;116:120-122.
34. Welmaker GS, Nelson JA, Sabalski JE, et al. Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4, 4a-tetrahydro-1H-pyrazino[1,2-a] quinoxalin-5-(6H)ones and 2,3,4,4a,5, 6-hexahydro-1H-pyrazino[1,2-a] quinoxalines. Bioorg Med Chem Lett 2000;10:1991-1994.
35. Woods A, Smith C, Szewczak M, Dunn RW, Cornfeldt M, Corbett R. Selective serotonin reuptake inhibitors decrease schedule-induced polydipsia in rats: A potential model for obsessive-compulsive disorder. Psychopharmacology 1993;112:195-198.